KATRINA DAAE: Open Payments
NPI 1346661873 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 48 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $90 · 2025 $883
Food & beverage: $771Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $188 |
| ABBVIE INC. | 11 | $159 |
| Lilly USA, LLC | 4 | $76 |
| Neurocrine BioSciences, Inc. | 3 | $59 |
| ARGENX US, INC. | 3 | $53 |
| Averitas Pharma Inc. | 3 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| PFIZER INC. | 2 | $39 |
| UCB, Inc. | 2 | $39 |
| Lundbeck LLC | 2 | $36 |
Products named: QULIPTA, AUSTEDO XR, INGREZZA, UBRELVY, AMYVID, VYVGART HYTRULO, QUTENZA, SPRAVATO.
Industry payments across NJ — which companies pay providers there.
